Global investment firm Permira has appointed Jason Wreath as a senior adviser to its global healthcare team.

Wreath has more than two decades’ experience in technology and life sciences. He is currently the worldwide head of data and AI solutions at Amazon Web Services, where he leads the development and implementation of solutions to business challenges for a range of industry and technology use cases, including healthcare.

Wreath began his career as a pharmaceutical chemist and has since established himself at the intersection of pharma and technology. He has held a variety of leadership roles in healthcare-focused start-ups and global tech companies, including Symphony Health, Veeva Systems, HIK, HealthTap, and Kythera Labs.

Wreath has been working with Permira’s healthcare and technology teams since 2019, initially on supporting thesis development for new opportunities, and over time he has developed his relationship and advisory work across the portfolio. He currently sits on the Ergomed Tech Council and has been involved in advising PharmaCord and Mercalis on the long-term tech strategy for the combined business.

Laura O’Donnell, healthcare managing director at Permira, said: “After many years of collaboration, we are thrilled to welcome Jason as a senior adviser to Permira. Jason is one of the rare individuals who has equally deep expertise in the worlds of pharma and AI. His perspective and experience are already having a positive impact across our healthcare platform, and we’re excited for the contributions he will continue to make as a senior adviser.”

Peter Michel, healthcare managing director at Permira, added: “Jason’s experience at the forefront of AI and analytics, paired with his deep understanding of healthcare, makes him an exceptional addition to our adviser group. We’ve worked closely with him across new investment opportunities and our portfolio for several years now and are excited to welcome him formally to the team.”

Wreath said: “Permira has consistently demonstrated its leadership in healthcare and commitment to improving the quality of healthcare provision globally. It’s a privilege to join as a senior adviser, and I look forward to continuing our work together to drive innovation and real-world impact across the healthcare ecosystem.”

Permira has deployed more than €5 billion to partner with 20-plus healthcare companies globally. Current investments from the Permira funds in the sector include PharmaCord, Ergomed, Kedrion Biopharma, Neuraxpharm, Cambrex, Quotient Sciences, I-MED, and Corin.